EUVIMED · CrossrefZeitschrift
Signal Transduction and Targeted Therapy
ISSN 2059-3635 · Springer Science and Business Media LLC
Neueste Artikel
Reinvigorating immunotherapy: harnessing tumor microenvironment modulation for enhanced cancer treatment
Immune niche remodeling: sustaining CAR-T persistence in solid tumors
Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer
Cell death: from basic principles to translational developments
Spatial transcriptomics tumor microenvironment determinants of tyrosine kinase inhibitor response in renal cell carcinoma: results from a phase 2 clinical trial
Targeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA
Citrate metabolism and mitochondrial DNA signaling: cooperative regulation of the senescence-associated secretory phenotype
Cancer drug resistance as a temporal process: cell plasticity, adaptive buffering, signaling pathways and therapeutic interception
MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades
Multi-omics, spatial omics and artificial intelligence in chronic diseases: current applications and future directions
Mutant KRAS vaccination for pancreatic cancer interception: the G12D immunogenicity paradox
Antibody-drug conjugates: unpacking toxicity profiles and optimized designs for enhanced safety and antitumor efficacy
Neutralization and protective effectiveness of three XBB vaccines in older adults 12 months after booster
Tumor vessel sabotage: CD4⁺ T cells enlist macrophages
An actionable GPCR restores phosphoinositide homeostasis and kidney function in Lowe syndrome
Epilepsy: epidemiology, risk factors, classification, pathophysiology, clinical features, diagnosis and management
Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reductase inhibition: SITGEM-CARE phase 2 trial
Neoadjuvant concurrent or sequential anthracycline-containing chemotherapy and HER2-targeted agents for HER2-positive breast cancer: a randomized phase 2 study (METIS)
Autoimmune-shared immune states converge in a CXCL12–CXCR4 fibroblast–immune niche in chronic antibody-mediated rejection
Complement deposition in the bone marrow of patients with myelodysplastic neoplasms
Cancer-associated fibroblasts: origins, functional heterogeneity and therapeutic potential
Primate embryoids: an in vitro model leading from a totipotency-like phase to early organogenesis
Synaptic transmission and plasticity: molecular mechanisms, biological functions and therapeutic opportunities in neurodegenerative diseases
Anti-PD1 immunotherapy in MHC-I dysregulated head and neck cancer promotes metastasis via CD8+ T-cell insufficiency
Aromaticity at spike position 456 affects functional immunogenicity of SARS-CoV-2 Omicron variant receptor-binding domain
The AMPK signaling pathway in cell metabolism and human diseases
HLA allele DRB1*01:03: the genetic link to neutralizing IL-10 antibodies in inflammatory bowel disease
Spatiotemporally resolved single-nucleus transcriptomics reveals cellular and regional vulnerability in the midbrain in Parkinson’s disease
Encapsulated mitochondrial transplantation: Advancing organelle therapeutics
Spatial transcriptomics identifies tumor-intrinsic and stromal programs associated with immune exclusion in NSCLC
EUVIMED